Edition:
United States

Lexicon Pharmaceuticals Inc (LXRX.OQ)

LXRX.OQ on NASDAQ Stock Exchange Global Select Market

10.44USD
3:59pm EST
Change (% chg)

$0.45 (+4.50%)
Prev Close
$9.99
Open
$9.97
Day's High
$10.61
Day's Low
$9.97
Volume
324,989
Avg. Vol
241,030
52-wk High
$17.96
52-wk Low
$8.10

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Raymond Debbane

62 2012 Independent Chairman of the Board

Lonnel Coats

52 2014 President, Chief Executive Officer, Director

Jeffrey Wade

52 2015 Chief Financial Officer, Executive Vice President - Corporate and Administrative Affairs

Pablo Lapuerta

53 2015 Executive Vice President, Chief Medical Officer

Alan Main

63 2015 Executive Vice President - CMC and Supply Operations